NCT01177566View on ClinicalTrials.gov

Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Atopic Dermatitis
Interventions
DRUG

pimecrolimus

pimecrolimus 1% cream twice daily

DEVICE

topical medical device

Eletone cream three times daily

Trial Locations (1)

10029

Mount Sinai School of Medicine Department of Dermatology Clinical Trials, New York

Sponsors

Collaborators (1)

Ferndale Laboratories
All Listed Sponsors
collaborator

Ferndale Laboratories

UNKNOWN

lead

Emer, Jason, M.D.

INDIV